These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 23077129)
1. Taxonomy and antifungal susceptibility of clinically important Rasamsonia species. Houbraken J; Giraud S; Meijer M; Bertout S; Frisvad JC; Meis JF; Bouchara JP; Samson RA J Clin Microbiol; 2013 Jan; 51(1):22-30. PubMed ID: 23077129 [TBL] [Abstract][Full Text] [Related]
2. First recovery of Rasamsonia argillacea species complex isolated in adolescent patient with cystic fibrosis in Slovenia--case report and review of literature. Matos T; Cerar T; Praprotnik M; Krivec U; Pirš M Mycoses; 2015 Aug; 58(8):506-10. PubMed ID: 26058584 [TBL] [Abstract][Full Text] [Related]
3. Rasamsonia, a new genus comprising thermotolerant and thermophilic Talaromyces and Geosmithia species. Houbraken J; Spierenburg H; Frisvad JC Antonie Van Leeuwenhoek; 2012 Feb; 101(2):403-21. PubMed ID: 21965082 [TBL] [Abstract][Full Text] [Related]
4. Identification and Antifungal Susceptibility of Penicillium-Like Fungi from Clinical Samples in the United States. Guevara-Suarez M; Sutton DA; Cano-Lira JF; García D; Martin-Vicente A; Wiederhold N; Guarro J; Gené J J Clin Microbiol; 2016 Aug; 54(8):2155-61. PubMed ID: 27280422 [TBL] [Abstract][Full Text] [Related]
5. Identification of Paecilomyces variotii in clinical samples and settings. Houbraken J; Verweij PE; Rijs AJ; Borman AM; Samson RA J Clin Microbiol; 2010 Aug; 48(8):2754-61. PubMed ID: 20519470 [TBL] [Abstract][Full Text] [Related]
6. Airway persistence by the emerging multi-azole-resistant Rasamsonia argillacea complex in cystic fibrosis. Abdolrasouli A; Bercusson AC; Rhodes JL; Hagen F; Buil JB; Tang AYY; de Boer LL; Shah A; Milburn AJ; Elborn JS; Jones AL; Meis JF; Fisher MC; Schelenz S; Simmonds NJ; Armstrong-James D Mycoses; 2018 Sep; 61(9):665-673. PubMed ID: 29702751 [TBL] [Abstract][Full Text] [Related]
7. Emergence of disseminated infections due to Geosmithia argillacea in patients with chronic granulomatous disease receiving long-term azole antifungal prophylaxis. Machouart M; Garcia-Hermoso D; Rivier A; Hassouni N; Catherinot E; Salmon A; Debourgogne A; Coignard H; Lecuit M; Bougnoux ME; Blanche S; Lortholary O J Clin Microbiol; 2011 Apr; 49(4):1681-3. PubMed ID: 21270214 [TBL] [Abstract][Full Text] [Related]
8. Isolation and identification of Geosmithia argillacea from a fungal ball in the lung of a tuberculosis patient. Sohn JY; Jang MA; Lee JH; Park KS; Ki CS; Lee NY Ann Lab Med; 2013 Mar; 33(2):136-40. PubMed ID: 23483122 [TBL] [Abstract][Full Text] [Related]
9. Multilocus Phylogeny and Antifungal Susceptibility of Aspergillus Section Circumdati from Clinical Samples and Description of A. pseudosclerotiorum sp. nov. Siqueira JP; Sutton DA; Gené J; García D; Wiederhold N; Peterson SW; Guarro J J Clin Microbiol; 2017 Mar; 55(3):947-958. PubMed ID: 28053212 [TBL] [Abstract][Full Text] [Related]
10. Long-Term Rasamsonia argillacea Complex Species Colonization Revealed by PCR Amplification of Repetitive DNA Sequences in Cystic Fibrosis Patients. Mouhajir A; Matray O; Giraud S; Mély L; Marguet C; Sermet-Gaudelus I; Le Gal S; Labbé F; Person C; Troussier F; Ballet JJ; Gargala G; Zouhair R; Bougnoux ME; Bouchara JP; Favennec L J Clin Microbiol; 2016 Nov; 54(11):2804-2812. PubMed ID: 27605712 [TBL] [Abstract][Full Text] [Related]
11. Geosmithia argillacea: an emerging cause of invasive mycosis in human chronic granulomatous disease. De Ravin SS; Challipalli M; Anderson V; Shea YR; Marciano B; Hilligoss D; Marquesen M; Decastro R; Liu YC; Sutton DA; Wickes BL; Kammeyer PL; Sigler L; Sullivan K; Kang EM; Malech HL; Holland SM; Zelazny AM Clin Infect Dis; 2011 Mar; 52(6):e136-43. PubMed ID: 21367720 [TBL] [Abstract][Full Text] [Related]
12. Molecular identification and susceptibility of Trichosporon species isolated from clinical specimens in Qatar: isolation of Trichosporon dohaense Taj-Aldeen, Meis & Boekhout sp. nov. Taj-Aldeen SJ; Al-Ansari N; El Shafei S; Meis JF; Curfs-Breuker I; Theelen B; Boekhout T J Clin Microbiol; 2009 Jun; 47(6):1791-9. PubMed ID: 19321719 [TBL] [Abstract][Full Text] [Related]
13. Phylogenetic Diversity and In Vitro Susceptibility Profiles of Human Pathogenic Members of the Fusarium fujikuroi Species Complex Isolated from South India. Tupaki-Sreepurna A; Thanneru V; Natarajan S; Sharma S; Gopi A; Sundaram M; Kindo AJ Mycopathologia; 2018 Jun; 183(3):529-540. PubMed ID: 29445920 [TBL] [Abstract][Full Text] [Related]
14. Risk factors and mortality in invasive Rasamsonia spp. infection: Analysis of cases in the FungiScope Stemler J; Salmanton-García J; Seidel D; Alexander BD; Bertz H; Hoenigl M; Herbrecht R; Meintker L; Meißner A; Mellinghoff SC; Sal E; Zarrouk M; Koehler P; Cornely OA Mycoses; 2020 Mar; 63(3):265-274. PubMed ID: 31769549 [TBL] [Abstract][Full Text] [Related]
15. Molecular Identification and Antifungal Susceptibility of Clinical Isolates of Sporothrix schenckii Complex in Medellin, Colombia. Flórez-Muñoz SV; Alzate JF; Mesa-Arango AC Mycopathologia; 2019 Feb; 184(1):53-63. PubMed ID: 30554299 [TBL] [Abstract][Full Text] [Related]
16. Antifungal susceptibility and phylogeny of opportunistic members of the order mucorales. Vitale RG; de Hoog GS; Schwarz P; Dannaoui E; Deng S; Machouart M; Voigt K; van de Sande WW; Dolatabadi S; Meis JF; Walther G J Clin Microbiol; 2012 Jan; 50(1):66-75. PubMed ID: 22075600 [TBL] [Abstract][Full Text] [Related]